1.
Komrokji RS, Carraway HE, Germing U, Wermke M, Zeidan AM, Fu E, RĂ¼ter B, Burkard U, Osswald A, Foran JM. A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome. haematol [Internet]. 2022Jun.23 [cited 2022Dec.8];107(11):2742-7. Available from: https://haematologica.org/article/view/haematol.2021.280500